Stock 688056 BEIJING LABTECH INSTRUMENTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Beijing Labtech Instruments Co., Ltd.

Equities

688056

CNE1000043C6

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
21.36 CNY +1.47% Intraday chart for Beijing Labtech Instruments Co., Ltd. -3.61% -36.26%
Apr. 25 Beijing Labtech Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Tranche Update on Beijing Labtech Instruments Co., Ltd.'s Equity Buyback Plan announced on February 29, 2024. CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 50% by 2026.
  • The company's profit outlook over the next few years is a strong asset.

Weaknesses

  • The firm trades with high earnings multiples: 25.28 times its 2024 earnings per share.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Office Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
BEIJING LABTECH INSTRUMENTS CO., LTD. Stock Beijing Labtech Instruments Co., Ltd.
-36.26% 198M -
SHIMADZU CORPORATION Stock Shimadzu Corporation
+6.72% 7.7B
B-
TECAN GROUP AG Stock Tecan Group AG
-7.40% 4.54B
B
OLINK HOLDING AB Stock Olink Holding AB
+2.43% 3.21B -
JEOL LTD. Stock JEOL Ltd.
+13.84% 2.26B -
ECKERT & ZIEGLER SE Stock Eckert & Ziegler SE
+11.48% 1.04B
C+
PARK SYSTEMS CORP. Stock Park Systems Corp.
+11.18% 970M -
NINGBO YONGXIN OPTICS CO.,LTD Stock Ningbo Yongxin Optics Co.,Ltd
-42.62% 872M -
FOCUSED PHOTONICS (HANGZHOU), INC. Stock Focused Photonics (Hangzhou), Inc.
-35.27% 633M -
MLOPTIC CORP. Stock MLOptic Corp.
-61.05% 614M -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. 688056 Stock
  4. Ratings Beijing Labtech Instruments Co., Ltd.